Polymerisation of cyanoacrylates: The effect of sclero-embolic and contrast agents

CONCLUSIONS: The commercially available medical cyanoacrylates differ in their polymerisation rates. These polymerisation rates are further affected when these products are used in conjunction with other compounds, such as sclero-embolic and contrast agents.PMID:37944534 | DOI:10.1177/02683555231214343

Source: Phlebology - November 9, 2023 Category: Internal Medicine Authors: Joseph Grac é David Connor Lourens Bester Christopher Rogan Kurosh Parsi Source Type: research